Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 298

1.

Using environmental clustering to identify specific drought tolerance QTLs in bread wheat (T. aestivum L.).

Touzy G, Rincent R, Bogard M, Lafarge S, Dubreuil P, Mini A, Deswarte JC, Beauchêne K, Le Gouis J, Praud S.

Theor Appl Genet. 2019 Oct;132(10):2859-2880. doi: 10.1007/s00122-019-03393-2. Epub 2019 Jul 19.

PMID:
31324929
2.

Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies.

Weisberg E, Meng C, Case AE, Sattler M, Tiv HL, Gokhale PC, Buhrlage SJ, Liu X, Yang J, Wang J, Gray N, Stone RM, Adamia S, Dubreuil P, Letard S, Griffin JD.

Br J Haematol. 2019 Nov;187(4):488-501. doi: 10.1111/bjh.16092. Epub 2019 Jul 15.

PMID:
31309543
3.

Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial.

Mora JS, Genge A, Chio A, Estol CJ, Chaverri D, Hernández M, Marín S, Mascias J, Rodriguez GE, Povedano M, Paipa A, Dominguez R, Gamez J, Salvado M, Lunetta C, Ballario C, Riva N, Mandrioli J, Moussy A, Kinet JP, Auclair C, Dubreuil P, Arnold V, Mansfield CD, Hermine O; AB10015 STUDY GROUP.

Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jul 7:1-10. doi: 10.1080/21678421.2019.1632346. [Epub ahead of print]

PMID:
31280619
4.

Neuroinflammatory disorders and mastocytosis: A possible association?

Rodrigues F, Edjlali M, Georgin-Lavialle S, Chandesris O, Barete S, Bouktit H, Dubreuil P, Hamidou M, Saadoun D, Gaillard R, Hermine O.

J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2878-2881.e1. doi: 10.1016/j.jaip.2019.04.033. Epub 2019 May 8. No abstract available.

PMID:
31077881
5.

Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort study.

Fradet M, Negretto M, Tournier E, Laurent C, Apoil PA, Evrard S, Degboe Y, Del Mas V, Lamant L, Dubreuil P, Laroche M, Mailhol C, Hermine O, Paul C, Bulai Livideanu C.

J Eur Acad Dermatol Venereol. 2019 Sep;33(9):1713-1718. doi: 10.1111/jdv.15638. Epub 2019 May 17.

PMID:
31009132
6.

Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS.

Lemal R, Fouquet G, Terriou L, Vaes M, Livideanu CB, Frenzel L, Barete S, Canioni D, Lhermitte L, Rossignol J, Arock M, Dubreuil P, Lortholary O, Hermine O.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2387-2395.e3. doi: 10.1016/j.jaip.2019.03.039. Epub 2019 Apr 5.

PMID:
30954641
7.

Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome.

Degboé Y, Eischen M, Apoil PA, Mailhol C, Dubreuil P, Hermine O, Paul C, Bulai Livideanu C, Laroche M.

Osteoporos Int. 2019 Jun;30(6):1235-1241. doi: 10.1007/s00198-019-04918-7. Epub 2019 Mar 7.

PMID:
30847528
8.

KIT as a therapeutic target for non-oncological diseases.

Martinez-Anton A, Gras D, Bourdin A, Dubreuil P, Chanez P.

Pharmacol Ther. 2019 May;197:11-37. doi: 10.1016/j.pharmthera.2018.12.008. Epub 2018 Dec 14. Review.

PMID:
30557630
9.

Mast cell activation syndrome: High frequency of skin manifestations and anaphylactic shock.

Casassa EA, Mailhol C, Tournier E, Laurent C, Degboe Y, Eischen M, Kirsten N, Moreau J, Evrard SM, Mansat-De Mas V, Lamant L, Dubreuil P, Apoil PA, Hermine O, Paul C, Bulai Livideanu C.

Allergol Int. 2019 Jan;68(1):119-121. doi: 10.1016/j.alit.2018.07.003. Epub 2018 Aug 7. No abstract available.

10.

Paediatric mastocytosis: long-term follow-up of 53 patients with whole sequencing of KIT. A prospective study.

Meni C, Georgin-Lavialle S, Le Saché de Peufeilhoux L, Jais JP, Hadj-Rabia S, Bruneau J, Fraitag S, Hanssens K, Dubreuil P, Hermine O, Bodemer C.

Br J Dermatol. 2018 Oct;179(4):925-932. doi: 10.1111/bjd.16795. Epub 2018 Sep 9.

PMID:
29787623
11.

The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.

Janovec V, Aouar B, Font-Haro A, Hofman T, Trejbalova K, Weber J, Chaperot L, Plumas J, Olive D, Dubreuil P, Nunès JA, Stranska R, Hirsch I.

Front Immunol. 2018 Feb 26;9:364. doi: 10.3389/fimmu.2018.00364. eCollection 2018.

12.

Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology.

Hammam K, Saez-Ayala M, Rebuffet E, Gros L, Lopez S, Hajem B, Humbert M, Baudelet E, Audebert S, Betzi S, Lugari A, Combes S, Letard S, Casteran N, Mansfield C, Moussy A, De Sepulveda P, Morelli X, Dubreuil P.

Nat Commun. 2017 Nov 10;8(1):1420. doi: 10.1038/s41467-017-01582-5.

13.

Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS.

Trias E, Ibarburu S, Barreto-Núñez R, Varela V, Moura IC, Dubreuil P, Hermine O, Beckman JS, Barbeito L.

JCI Insight. 2017 Oct 19;2(20). pii: 95934. doi: 10.1172/jci.insight.95934.

14.

The Horizontal Myocutaneous Infrahyoid Island Flap for Soft-Tissue Head and Oral Reconstruction: Step-by-Step Video Description.

Verbruggen C, Majoufre C, Derosamel L, Dubreuil PA, Vallade G, Mage C, Sessiecq Q, Bondaz M.

Plast Reconstr Surg. 2017 Oct;140(4):598e-600e. doi: 10.1097/PRS.0000000000003699.

PMID:
28953734
15.

Adult T cell leukemia aggressivenness correlates with loss of both 5-hydroxymethylcytosine and TET2 expression.

Marçais A, Waast L, Bruneau J, Hanssens K, Asnafi V, Gaulard P, Suarez F, Dubreuil P, Gessain A, Hermine O, Pique C.

Oncotarget. 2016 Nov 26;8(32):52256-52268. doi: 10.18632/oncotarget.13665. eCollection 2017 Aug 8.

16.

Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.

Olvedy M, Tisserand JC, Luciani F, Boeckx B, Wouters J, Lopez S, Rambow F, Aibar S, Thienpont B, Barra J, Köhler C, Radaelli E, Tartare-Deckert S, Aerts S, Dubreuil P, van den Oord JJ, Lambrechts D, De Sepulveda P, Marine JC.

J Clin Invest. 2017 Jun 1;127(6):2310-2325. doi: 10.1172/JCI91291. Epub 2017 May 2.

17.

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.

Lortholary O, Chandesris MO, Bulai Livideanu C, Paul C, Guillet G, Jassem E, Niedoszytko M, Barete S, Verstovsek S, Grattan C, Damaj G, Canioni D, Fraitag S, Lhermitte L, Georgin Lavialle S, Frenzel L, Afrin LB, Hanssens K, Agopian J, Gaillard R, Kinet JP, Auclair C, Mansfield C, Moussy A, Dubreuil P, Hermine O.

Lancet. 2017 Feb 11;389(10069):612-620. doi: 10.1016/S0140-6736(16)31403-9. Epub 2017 Jan 7.

18.

Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils.

Malbec O, Cassard L, Albanesi M, Jönsson F, Mancardi D, Chicanne G, Payrastre B, Dubreuil P, Vivier E, Daëron M.

Sci Signal. 2016 Dec 20;9(459):ra126. doi: 10.1126/scisignal.aag1401.

PMID:
27999175
19.

General and specific combining abilities in a maize (Zea mays L.) test-cross hybrid panel: relative importance of population structure and genetic divergence between parents.

Larièpe A, Moreau L, Laborde J, Bauland C, Mezmouk S, Décousset L, Mary-Huard T, Fiévet JB, Gallais A, Dubreuil P, Charcosset A.

Theor Appl Genet. 2017 Feb;130(2):403-417. doi: 10.1007/s00122-016-2822-z. Epub 2016 Dec 2.

PMID:
27913832
20.

Familial hematological malignancies: new IDH2 mutation.

Hamadou WS, Bourdon V, Létard S, Brenet F, Laarif S, Besbes S, Paci A, David M, Penard-Lacronique V, Youssef YB, Laatiri MA, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Noguchi T, Khélif A, Salem CB, Dubreuil P, Sobol H, Soua Z.

Ann Hematol. 2016 Dec;95(12):1943-1947. Epub 2016 Sep 3.

PMID:
27591990
21.

Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.

Georgin-Lavialle S, Moura DS, Salvador A, Chauvet-Gelinier JC, Launay JM, Damaj G, Côté F, Soucié E, Chandesris MO, Barète S, Grandpeix-Guyodo C, Bachmeyer C, Alyanakian MA, Aouba A, Lortholary O, Dubreuil P, Teyssier JR, Trojak B, Haffen E, Vandel P, Bonin B; French Mast Cell Study Group, Hermine O, Gaillard R.

Mol Psychiatry. 2016 Nov;21(11):1511-1516. doi: 10.1038/mp.2015.216. Epub 2016 Jan 26.

PMID:
26809839
22.

Mast cell sarcoma: new cases and literature review.

Monnier J, Georgin-Lavialle S, Canioni D, Lhermitte L, Soussan M, Arock M, Bruneau J, Dubreuil P, Bodemer C, Chandesris MO, Lortholary O, Hermine O, Damaj G.

Oncotarget. 2016 Oct 4;7(40):66299-66309. doi: 10.18632/oncotarget.11812. Review.

23.

[Arthrocentesis of the temporomandibular joint and intra-articular injections : An update].

Marty P, Louvrier A, Weber E, Dubreuil PA, Chatelain B, Meyer C.

Rev Stomatol Chir Maxillofac Chir Orale. 2016 Sep;117(4):266-72. doi: 10.1016/j.revsto.2016.07.020. Epub 2016 Aug 21. Review. French.

PMID:
27554488
24.

Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis.

Trias E, Ibarburu S, Barreto-Núñez R, Babdor J, Maciel TT, Guillo M, Gros L, Dubreuil P, Díaz-Amarilla P, Cassina P, Martínez-Palma L, Moura IC, Beckman JS, Hermine O, Barbeito L.

J Neuroinflammation. 2016 Jul 11;13(1):177. doi: 10.1186/s12974-016-0620-9.

25.

Midostaurin in Advanced Systemic Mastocytosis.

Chandesris MO, Damaj G, Canioni D, Brouzes C, Lhermitte L, Hanssens K, Frenzel L, Cherquaoui Z, Durieu I, Durupt S, Gyan E, Beyne-Rauzy O, Launay D, Faure C, Hamidou M, Besnard S, Diouf M, Schiffmann A, Niault M, Jeandel PY, Ranta D, Gressin R, Chantepie S, Barete S, Dubreuil P, Bourget P, Lortholary O, Hermine O; CEREMAST Study Group.

N Engl J Med. 2016 Jun 30;374(26):2605-7. doi: 10.1056/NEJMc1515403. No abstract available.

PMID:
27355555
26.

An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemia.

Lopez S, Voisset E, Tisserand JC, Mosca C, Prebet T, Santamaria D, Dubreuil P, De Sepulveda P.

Oncotarget. 2016 Aug 9;7(32):51163-51173. doi: 10.18632/oncotarget.9965.

27.

Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients.

Rouet A, Aouba A, Damaj G, Soucié E, Hanssens K, Chandesris MO, Livideanu CB, Dutertre M, Durieu I, Grandpeix-Guyodo C, Barète S, Bachmeyer C, Soria A, Frenzel L, Fain O, Grosbois B, de Gennes C, Hamidou M, Arlet JB, Launay D, Lavigne C, Arock M, Lortholary O, Dubreuil P, Hermine O, Georgin-Lavialle S.

Medicine (Baltimore). 2016 Jun;95(24):e3901. doi: 10.1097/MD.0000000000003901. Erratum in: Medicine (Baltimore). 2016 Aug 07;95(31):e5074.

28.

Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells.

Aouar B, Kovarova D, Letard S, Font-Haro A, Florentin J, Weber J, Durantel D, Chaperot L, Plumas J, Trejbalova K, Hejnar J, Nunès JA, Olive D, Dubreuil P, Hirsch I, Stranska R.

PLoS One. 2016 Jun 3;11(6):e0156063. doi: 10.1371/journal.pone.0156063. eCollection 2016.

29.

Screening of candidate G-quadruplex ligands for the human c-KIT promotorial region and their effects in multiple in-vitro models.

Zorzan E, Da Ros S, Musetti C, Shahidian LZ, Coelho NF, Bonsembiante F, Létard S, Gelain ME, Palumbo M, Dubreuil P, Giantin M, Sissi C, Dacasto M.

Oncotarget. 2016 Apr 19;7(16):21658-75. doi: 10.18632/oncotarget.7808.

30.

Telangiectasia macularis eruptiva perstans (TMEP): A form of cutaneous mastocytosis with potential systemic involvement.

Severino M, Chandesris MO, Barete S, Tournier E, Sans B, Laurent C, Apoil PA, Lamant L, Mailhol C, Laroche M, Fraitag S, Hanssens K, Dubreuil P, Hermine O, Paul C, Bulai Livideanu C.

J Am Acad Dermatol. 2016 May;74(5):885-91.e1. doi: 10.1016/j.jaad.2015.10.050. Epub 2016 Feb 19.

PMID:
26899198
31.

DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.

Scourzic L, Couronné L, Pedersen MT, Della Valle V, Diop M, Mylonas E, Calvo J, Mouly E, Lopez CK, Martin N, Fontenay M, Bender A, Guibert S, Dubreuil P, Dessen P, Droin N, Pflumio F, Weber M, Gaulard P, Helin K, Mercher T, Bernard OA.

Leukemia. 2016 Jun;30(6):1388-98. doi: 10.1038/leu.2016.29. Epub 2016 Feb 15.

32.

Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms.

Georgin-Lavialle S, Launay JM, Côté F, Soucié E, Soria A, Damaj G, Moura DS, Canioni D, Hanssens K, Chandesris MO, Barète S, Dubreuil P, Lortholary O, Hermine O, Sokol H.

Allergy. 2016 Mar;71(3):416-20. doi: 10.1111/all.12802. Epub 2015 Dec 24.

33.

Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells.

Soucie EL, Weng Z, Geirsdóttir L, Molawi K, Maurizio J, Fenouil R, Mossadegh-Keller N, Gimenez G, VanHille L, Beniazza M, Favret J, Berruyer C, Perrin P, Hacohen N, Andrau JC, Ferrier P, Dubreuil P, Sidow A, Sieweke MH.

Science. 2016 Feb 12;351(6274):aad5510. doi: 10.1126/science.aad5510. Epub 2016 Jan 21.

34.

Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.

Bulai Livideanu C, Apoil PA, Lepage B, Eischen M, Laurent C, Laharrague P, Lamant L, Tournier E, Tavitian S, Pouplard C, Recher C, Laroche M, Mailhol C, Dubreuil P, Hermine O, Blancher A, Paul C.

Clin Exp Allergy. 2016 Jan;46(1):133-41. doi: 10.1111/cea.12627.

PMID:
26767494
35.

Rapid and clinically significant response to masitinib in the treatment of mucosal primary esophageal melanoma with somatic KIT exon 11 mutation involving brain metastases: A case report.

Prosvicova J, Lukesova S, Kopecky J, Grim J, Papik Z, Kolarova R, Navratilova B, Dubreuil P, Agopian J, Mansfield C, Moussy A, Hermine O.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Dec;159(4):695-7. doi: 10.5507/bp.2015.061. Epub 2015 Nov 27.

36.

Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell Tumors.

Zorzan E, Hanssens K, Giantin M, Dacasto M, Dubreuil P.

PLoS One. 2015 Nov 12;10(11):e0142450. doi: 10.1371/journal.pone.0142450. eCollection 2015.

37.

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.

Barete S, Lortholary O, Damaj G, Hirsch I, Chandesris MO, Elie C, Hamidou M, Durieu I, Suarez F, Grosbois B, Limal N, Gyan E, Larroche C, Guillet G, Kahn JE, Casassus P, Amazzough K, Coignard-Biehler H, Georgin-Lavialle S, Lhermitte L, Fraitag S, Canioni D, Dubreuil P, Hermine O.

Blood. 2015 Aug 20;126(8):1009-16; quiz 1050. doi: 10.1182/blood-2014-12-614743. Epub 2015 May 22.

PMID:
26002962
38.

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer.

Deplanque G, Demarchi M, Hebbar M, Flynn P, Melichar B, Atkins J, Nowara E, Moyé L, Piquemal D, Ritter D, Dubreuil P, Mansfield CD, Acin Y, Moussy A, Hermine O, Hammel P.

Ann Oncol. 2015 Jun;26(6):1194-200. doi: 10.1093/annonc/mdv133. Epub 2015 Apr 9.

39.

Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.

Förster A, Grotha SP, Seeger JM, Rabenhorst A, Gehring M, Raap U, Létard S, Dubreuil P, Kashkar H, Walczak H, Roers A, Hartmann K.

Allergy. 2015 Jul;70(7):764-74. doi: 10.1111/all.12612. Epub 2015 Apr 16.

PMID:
25833810
40.

Paediatric mastocytosis: a systematic review of 1747 cases.

Méni C, Bruneau J, Georgin-Lavialle S, Le Saché de Peufeilhoux L, Damaj G, Hadj-Rabia S, Fraitag S, Dubreuil P, Hermine O, Bodemer C.

Br J Dermatol. 2015 Mar;172(3):642-51. doi: 10.1111/bjd.13567. Epub 2015 Feb 8. Review.

PMID:
25662299
41.

KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.

Arock M, Sotlar K, Akin C, Broesby-Olsen S, Hoermann G, Escribano L, Kristensen TK, Kluin-Nelemans HC, Hermine O, Dubreuil P, Sperr WR, Hartmann K, Gotlib J, Cross NC, Haferlach T, Garcia-Montero A, Orfao A, Schwaab J, Triggiani M, Horny HP, Metcalfe DD, Reiter A, Valent P.

Leukemia. 2015 Jun;29(6):1223-32. doi: 10.1038/leu.2015.24. Epub 2015 Feb 4. Review.

42.

Isolated flushes without permanent, fixed or other skin lesions in patients with systemic mastocytosis: a case series of 9 patients.

Lafont E, Lhermitte L, Damaj G, Soucie E, Barete S, Chandesris MO, Cabaret L, Guichard I, Durieu I, Retornaz F, Sarrot-Reynauld F, Hamidou M, Bruneau J, Aouba A, Dubreuil P, Lortholary O, Asnafi V, Hermine O, Georgin-Lavialle S.

Eur J Dermatol. 2015 Apr;25(2):182-4. doi: 10.1684/ejd.2014.2484. No abstract available.

PMID:
25547160
43.

Neuroprotective effect of masitinib in rats with postischemic stroke.

Kocic I, Kowianski P, Rusiecka I, Lietzau G, Mansfield C, Moussy A, Hermine O, Dubreuil P.

Naunyn Schmiedebergs Arch Pharmacol. 2015 Jan;388(1):79-86. doi: 10.1007/s00210-014-1061-6. Epub 2014 Oct 26.

44.

A genome-wide identification of chromosomal regions determining nitrogen use efficiency components in wheat (Triticum aestivum L.).

Cormier F, Le Gouis J, Dubreuil P, Lafarge S, Praud S.

Theor Appl Genet. 2014 Dec;127(12):2679-93. doi: 10.1007/s00122-014-2407-7. Epub 2014 Oct 19.

PMID:
25326179
45.

Characterization of S628N: a novel KIT mutation found in a metastatic melanoma.

Vita M, Tisserand JC, Chauvot de Beauchêne I, Panel N, Tchertanov L, Agopian J, Mescam-Mancini L, Fouet B, Fournier B, Dubreuil P, Bertucci F, De Sepulveda P.

JAMA Dermatol. 2014 Dec;150(12):1345-9.

PMID:
25317746
46.

Response to letter from Dr Jain.

Zandecki M, Dubreuil P.

Int J Lab Hematol. 2015 Aug;37(4):e64. doi: 10.1111/ijlh.12300. Epub 2014 Oct 13. No abstract available.

PMID:
25307985
47.

Dent and Flint maize diversity panels reveal important genetic potential for increasing biomass production.

Rincent R, Nicolas S, Bouchet S, Altmann T, Brunel D, Revilla P, Malvar RA, Moreno-Gonzalez J, Campo L, Melchinger AE, Schipprack W, Bauer E, Schoen CC, Meyer N, Ouzunova M, Dubreuil P, Giauffret C, Madur D, Combes V, Dumas F, Bauland C, Jamin P, Laborde J, Flament P, Moreau L, Charcosset A.

Theor Appl Genet. 2014 Nov;127(11):2313-31. doi: 10.1007/s00122-014-2379-7. Epub 2014 Oct 10.

PMID:
25301321
48.

Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial.

Adenis A, Blay JY, Bui-Nguyen B, Bouché O, Bertucci F, Isambert N, Bompas E, Chaigneau L, Domont J, Ray-Coquard I, Blésius A, Van Tine BA, Bulusu VR, Dubreuil P, Mansfield CD, Acin Y, Moussy A, Hermine O, Le Cesne A.

Ann Oncol. 2014 Sep;25(9):1762-9. doi: 10.1093/annonc/mdu237. Epub 2014 Jul 25.

49.

Hotspot mutations in KIT receptor differentially modulate its allosterically coupled conformational dynamics: impact on activation and drug sensitivity.

Chauvot de Beauchêne I, Allain A, Panel N, Laine E, Trouvé A, Dubreuil P, Tchertanov L.

PLoS Comput Biol. 2014 Jul 31;10(7):e1003749. doi: 10.1371/journal.pcbi.1003749. eCollection 2014 Jul.

50.

Molecular basis of mast cell disease.

Soucie E, Brenet F, Dubreuil P.

Mol Immunol. 2015 Jan;63(1):55-60. doi: 10.1016/j.molimm.2014.03.013. Epub 2014 Apr 24. Review.

PMID:
24768320

Supplemental Content

Loading ...
Support Center